Your browser doesn't support javascript.
loading
Alternative prostate cancer grading systems incorporating percent pattern 4/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomy.
Seyrek, Neslisah; Hollemans, Eva; Andrinopoulou, Eleni-Rosalina; Osanto, Susanne; Pelger, Rob C M; van der Poel, Henk G; Bekers, Elise; Remmers, Sebastiaan; Schoots, Ivo G; van Leenders, Geert J L H.
Afiliação
  • Seyrek N; Department of Pathology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. n.seyrek@erasmusmc.nl.
  • Hollemans E; Department of Radiology & Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands. n.seyrek@erasmusmc.nl.
  • Andrinopoulou ER; Department of Pathology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
  • Osanto S; Department of Biostatistics, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
  • Pelger RCM; Department of Epidemiology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
  • van der Poel HG; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Bekers E; Department of Urology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Remmers S; Department of Urology, Antoni Van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Schoots IG; Department of Pathology, Antoni Van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Leenders GJLH; Department of Urology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Virchows Arch ; 480(6): 1149-1157, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35157140
ABSTRACT
Percentage Gleason pattern 4, invasive cribriform and/or intraductal carcinoma (IC/IDC) and minor pattern 5 are recognized as independent parameters for prostate cancer outcome, but are not incorporated in current grade groups (GGs). Two proof-of-principle studies have proposed alternative grading schemes based on percentage Gleason pattern 4/5 (integrated quantitative Gleason score; IQ-Gleason) and IC/IDC presence (cribriform grade; cGrade). Our objective was to compare the performance of GG, IQ-Gleason and cGrade for predicting biochemical recurrence and metastasis after radical prostatectomy (RP). RP specimens of 1064 patients were pathologically reviewed and graded according to the three schemes. Discriminative power for prediction of biochemical recurrence-free (BCRFS) and metastasis-free (MFS) survival was compared using Harrell's c-index. The GG distribution at RP was 207 (19.4%) GG1, 472 (44.4%) GG2, 126 (11.8%) GG3, 140 (13.2%) GG4 and 119 (11.2%) GG5. Grading according to 5-tier IQ-Gleason and cGrade systems led to categorical shifts in 49.8% and 29.7% of cases, respectively. Continuous IQ-Gleason had the best performance for predicting BCRFS (c-index 0.743, 95% confidence interval (CI) 0.715-0.771), followed by cGrade (c-index 0.738, 95%CI 0.712-0.759), 5-tier categorical IQ-Gleason (c-index 0.723, 95%CI 0.695-0.750) and GG (c-index 0.718, 95%CI 0.691-0.744). Continuous IQ-Gleason (c-index 0.834, 95%CI 0.802-0.863) and cGrade (c-index 0.834, 95%CI 0.808-0.866) both had better predictive value for MFS than categorical IQ-Gleason (c-index 0.823, 95%CI 0.788-0.857) and GG (c-index 0.806, 95%CI 0.777-0.839). In conclusion, the performance of prostate cancer grading can be improved by alternative grading schemes incorporating percent Gleason pattern 4/5 and IC/IDC.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Carcinoma Intraductal não Infiltrante Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Carcinoma Intraductal não Infiltrante Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article